CA Stock MarketDetailed Quotes

NARA PanGenomic Health Inc

Watchlist
  • 0.145
  • 0.0000.00%
15min DelayMarket Closed Dec 24 10:42 ET
927.97KMarket Cap-0.01P/E (TTM)

PanGenomic Health Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-47.29%197.22K
-74.54%231.46K
-80.71%203.26K
-21.51%2.86M
-48.35%521.33K
-62.69%374.14K
12.52%908.96K
28.23%1.05M
319.25%3.64M
68.06%1.01M
Selling and administrative expenses
-50.58%173.04K
-73.21%214.52K
-74.19%213.2K
-18.92%2.46M
-47.19%481.34K
-59.06%350.14K
30.95%800.61K
26.38%825.9K
322.34%3.03M
98.46%911.54K
-Selling and marketing expense
--0
--0
-85.84%6.45K
-43.39%280.61K
56.34%204.75K
-88.99%18.06K
-81.82%12.23K
-65.82%45.57K
507.28%495.69K
60.44%130.96K
-General and administrative expense
-47.89%173.04K
-72.79%214.52K
-73.51%206.74K
-14.14%2.18M
-64.57%276.59K
-51.95%332.08K
44.90%788.38K
50.01%780.33K
298.61%2.54M
106.67%780.58K
Research and development costs
62.62%-616
-85.56%9.37K
-115.13%-24.21K
-52.48%253.78K
-52.50%30.58K
-101.39%-1.65K
-66.14%64.87K
0.27%159.98K
311.90%534.11K
-50.35%64.39K
Depreciation amortization depletion
-32.46%2.11K
0.00%3.13K
3.47%3.13K
11.60%12.4K
5.29%3.13K
7.94%3.13K
14.93%3.13K
19.64%3.02K
422.47%11.11K
39.63%2.97K
-Depreciation and amortization
-32.46%2.11K
0.00%3.13K
3.47%3.13K
11.60%12.4K
5.29%3.13K
7.94%3.13K
14.93%3.13K
19.64%3.02K
422.47%11.11K
39.63%2.97K
Other operating expenses
0.70%22.68K
-88.97%4.45K
-82.84%11.15K
106.64%134.14K
-79.43%6.28K
-13.41%22.52K
1,828.97%40.35K
933.10%64.98K
241.22%64.91K
220.54%30.52K
Operating profit
47.29%-197.22K
74.54%-231.46K
80.71%-203.26K
21.51%-2.86M
48.35%-521.33K
62.69%-374.14K
-12.52%-908.96K
-28.23%-1.05M
-319.25%-3.64M
-68.06%-1.01M
Net non-operating interest income (expenses)
96.02%-461
-49.13%-13.35K
-757.81%-19.72K
-3,744.27%-41.65K
-5,124.17%-18.81K
-7,829.33%-11.59K
-1,210.92%-8.95K
-520.29%-2.3K
-91.45%1.14K
-110.50%-360
Non-operating interest income
-95.58%25
-88.59%63
-90.83%63
-2.89%2.38K
2.84%579
17.46%565
-31.51%552
-17.03%687
-84.51%2.45K
-83.57%563
Non-operating interest expense
-96.00%486
41.13%13.42K
562.56%19.78K
3,259.04%44.04K
2,000.33%19.39K
3,573.41%12.16K
--9.51K
962.63%2.99K
-46.84%1.31K
--923
Other net income (expenses)
-5,177.48%-2.3M
308.26%4.23K
99.13%-72.94K
99.85%-12.74K
-788.48%-14.64K
-5,354.76%-43.53K
-2.03K
-365.63%-8.35M
-8.35M
Gain on sale of security
----
-137.12%-17.31K
308.26%4.23K
-479.69%-28.36K
-309.22%-12.85K
-390.60%-6.18K
-814.91%-7.3K
---2.03K
--7.47K
--6.14K
Special income (charges)
--0
-6,193.26%-2.28M
----
99.47%-44.58K
100.00%112
---8.46K
---36.23K
----
-366.05%-8.36M
---8.36M
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
366.05%8.36M
----
-Less:Other special charges
----
--2.28M
----
---37.46K
----
----
----
----
----
----
-Less:Write off
--0
--0
----
--82.04K
--37.34K
--8.46K
--36.23K
----
--0
--0
Income before tax
50.63%-197.68K
-164.40%-2.54M
79.33%-218.75K
75.21%-2.97M
94.10%-552.87K
59.98%-400.38K
-19.02%-961.44K
-28.84%-1.06M
-352.73%-11.99M
-291.63%-9.36M
Income tax
Earnings from equity interest net of tax
Net income
50.63%-197.68K
-164.40%-2.54M
79.33%-218.75K
75.21%-2.97M
94.10%-552.87K
59.98%-400.38K
-19.02%-961.44K
-28.84%-1.06M
-352.73%-11.99M
-291.63%-9.36M
Net income continuous operations
50.63%-197.68K
-164.40%-2.54M
79.33%-218.75K
75.21%-2.97M
94.10%-552.87K
59.98%-400.38K
-19.02%-961.44K
-28.84%-1.06M
-352.73%-11.99M
-291.63%-9.36M
Noncontrolling interests
Net income attributable to the company
50.63%-197.68K
-164.40%-2.54M
79.33%-218.75K
75.21%-2.97M
94.10%-552.87K
59.98%-400.38K
-19.02%-961.44K
-28.84%-1.06M
-352.73%-11.99M
-291.63%-9.36M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
50.63%-197.68K
-164.40%-2.54M
79.33%-218.75K
75.21%-2.97M
94.10%-552.87K
59.98%-400.38K
-19.02%-961.44K
-28.84%-1.06M
-352.73%-11.99M
-291.63%-9.36M
Diluted earnings per share
85.00%-0.15
-140.00%-1.2
81.82%-0.1
86.30%-15
94.69%-0.2634
0.00%-1
42.29%-0.5
47.43%-0.55
-3,127.38%-109.5
-62.88%-4.9615
Basic earnings per share
85.00%-0.15
-140.00%-1.2
81.82%-0.1
86.30%-15
94.69%-0.2634
0.00%-1
42.29%-0.5
47.43%-0.55
-3,127.38%-109.5
-62.88%-4.9615
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -47.29%197.22K-74.54%231.46K-80.71%203.26K-21.51%2.86M-48.35%521.33K-62.69%374.14K12.52%908.96K28.23%1.05M319.25%3.64M68.06%1.01M
Selling and administrative expenses -50.58%173.04K-73.21%214.52K-74.19%213.2K-18.92%2.46M-47.19%481.34K-59.06%350.14K30.95%800.61K26.38%825.9K322.34%3.03M98.46%911.54K
-Selling and marketing expense --0--0-85.84%6.45K-43.39%280.61K56.34%204.75K-88.99%18.06K-81.82%12.23K-65.82%45.57K507.28%495.69K60.44%130.96K
-General and administrative expense -47.89%173.04K-72.79%214.52K-73.51%206.74K-14.14%2.18M-64.57%276.59K-51.95%332.08K44.90%788.38K50.01%780.33K298.61%2.54M106.67%780.58K
Research and development costs 62.62%-616-85.56%9.37K-115.13%-24.21K-52.48%253.78K-52.50%30.58K-101.39%-1.65K-66.14%64.87K0.27%159.98K311.90%534.11K-50.35%64.39K
Depreciation amortization depletion -32.46%2.11K0.00%3.13K3.47%3.13K11.60%12.4K5.29%3.13K7.94%3.13K14.93%3.13K19.64%3.02K422.47%11.11K39.63%2.97K
-Depreciation and amortization -32.46%2.11K0.00%3.13K3.47%3.13K11.60%12.4K5.29%3.13K7.94%3.13K14.93%3.13K19.64%3.02K422.47%11.11K39.63%2.97K
Other operating expenses 0.70%22.68K-88.97%4.45K-82.84%11.15K106.64%134.14K-79.43%6.28K-13.41%22.52K1,828.97%40.35K933.10%64.98K241.22%64.91K220.54%30.52K
Operating profit 47.29%-197.22K74.54%-231.46K80.71%-203.26K21.51%-2.86M48.35%-521.33K62.69%-374.14K-12.52%-908.96K-28.23%-1.05M-319.25%-3.64M-68.06%-1.01M
Net non-operating interest income (expenses) 96.02%-461-49.13%-13.35K-757.81%-19.72K-3,744.27%-41.65K-5,124.17%-18.81K-7,829.33%-11.59K-1,210.92%-8.95K-520.29%-2.3K-91.45%1.14K-110.50%-360
Non-operating interest income -95.58%25-88.59%63-90.83%63-2.89%2.38K2.84%57917.46%565-31.51%552-17.03%687-84.51%2.45K-83.57%563
Non-operating interest expense -96.00%48641.13%13.42K562.56%19.78K3,259.04%44.04K2,000.33%19.39K3,573.41%12.16K--9.51K962.63%2.99K-46.84%1.31K--923
Other net income (expenses) -5,177.48%-2.3M308.26%4.23K99.13%-72.94K99.85%-12.74K-788.48%-14.64K-5,354.76%-43.53K-2.03K-365.63%-8.35M-8.35M
Gain on sale of security -----137.12%-17.31K308.26%4.23K-479.69%-28.36K-309.22%-12.85K-390.60%-6.18K-814.91%-7.3K---2.03K--7.47K--6.14K
Special income (charges) --0-6,193.26%-2.28M----99.47%-44.58K100.00%112---8.46K---36.23K-----366.05%-8.36M---8.36M
-Less:Impairment of capital assets --------------0----------------366.05%8.36M----
-Less:Other special charges ------2.28M-------37.46K------------------------
-Less:Write off --0--0------82.04K--37.34K--8.46K--36.23K------0--0
Income before tax 50.63%-197.68K-164.40%-2.54M79.33%-218.75K75.21%-2.97M94.10%-552.87K59.98%-400.38K-19.02%-961.44K-28.84%-1.06M-352.73%-11.99M-291.63%-9.36M
Income tax
Earnings from equity interest net of tax
Net income 50.63%-197.68K-164.40%-2.54M79.33%-218.75K75.21%-2.97M94.10%-552.87K59.98%-400.38K-19.02%-961.44K-28.84%-1.06M-352.73%-11.99M-291.63%-9.36M
Net income continuous operations 50.63%-197.68K-164.40%-2.54M79.33%-218.75K75.21%-2.97M94.10%-552.87K59.98%-400.38K-19.02%-961.44K-28.84%-1.06M-352.73%-11.99M-291.63%-9.36M
Noncontrolling interests
Net income attributable to the company 50.63%-197.68K-164.40%-2.54M79.33%-218.75K75.21%-2.97M94.10%-552.87K59.98%-400.38K-19.02%-961.44K-28.84%-1.06M-352.73%-11.99M-291.63%-9.36M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 50.63%-197.68K-164.40%-2.54M79.33%-218.75K75.21%-2.97M94.10%-552.87K59.98%-400.38K-19.02%-961.44K-28.84%-1.06M-352.73%-11.99M-291.63%-9.36M
Diluted earnings per share 85.00%-0.15-140.00%-1.281.82%-0.186.30%-1594.69%-0.26340.00%-142.29%-0.547.43%-0.55-3,127.38%-109.5-62.88%-4.9615
Basic earnings per share 85.00%-0.15-140.00%-1.281.82%-0.186.30%-1594.69%-0.26340.00%-142.29%-0.547.43%-0.55-3,127.38%-109.5-62.88%-4.9615
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data